Home › Endometrial Cancer › Montana › Kalispell
Endometrial Cancer clinical trials in Kalispell, MT
3 studies for Endometrial Cancer are looking for participants at sites in and around Kalispell (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
RecruitingPhase 2
- Logan Health Medical Center, Kalispell
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
RecruitingPhase 2
- Logan Health Medical Center, Kalispell
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
RecruitingPhase 3
- Logan Health Medical Center, Kalispell
Endometrial Cancer trials in other cities
- Houston, TX69 studies
- New York City, NY54 studies
- Boston, MA51 studies
- Arlington, VA41 studies
- Nashville, TN38 studies
- Los Angeles, CA35 studies
- St. Louis, MO29 studies
- Philadelphia, PA29 studies
- Oklahoma City, OK28 studies
- San Antonio, TX27 studies
- Queens, NY26 studies
- Dallas, TX25 studies
Other studies in Kalispell
- Non-Small Cell Lung Cancer10 studies
- Prostate Cancer9 studies
- Lung Cancer8 studies
- Acute Myeloid Leukemia7 studies
- Head and Neck Squamous Cell Carcinoma5 studies
- Melanoma5 studies
- Bladder Cancer4 studies
- Colorectal Cancer4 studies
- Colon Cancer4 studies
- Kidney Cancer (Renal Cell Carcinoma)3 studies
- Chronic Lymphocytic Leukemia3 studies
- Breast Cancer3 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.